The global arrhythmia monitoring devices market size is expected to reach USD 8.41 billion in 2025 with a CAGR of 6.8% during the forecast period, according to a new report by Grand View Research, Inc. Continuous R&D activities in the field of cardiac monitoring are leading to technological expansion. This, in turn, is positively influencing the growth of the arrhythmia monitoring devices market. Wearable diagnostic patch by iRhythm Technologies, Inc., Zio, has led to symptomatic arrhythmia monitoring, which is superior in comparison to conventional Holter monitors.
Big
pharma and medical device companies are heavily investing in R&D to perform
a detailed mapping of cardiac arrhythmia. In February 2018, Medtronic received
FDA clearance for the first non-invasive cardiac mapping system, CardioInsight.
It includes wearable 252-electrode sensor vest that creates 3D electroanatomic
maps of heart by combining data from a cardiac computed tomography scan with
ECG signals collected from the chest region.
In
addition to these technologies, emergence and advancements in mobile cardiac
telemetry are leading to further progress of the overall market. In October
2017, Abbott received FDA clearance for Confirm Rx, a smartphone-compatible
implantable cardiac monitor indicated for arrhythmia diagnosis. Boston
Scientific announced its FDA approval for Resonate, a line of cardiac
resynchronization therapy defibrillator and cardioverter defibrillator systems
for the cardiac management.
Full Research Report On Arrhythmia Monitoring Devices Market Visit Here:
https://www.grandviewresearch.com/industry-analysis/arrhythmia-monitoring-devices-market
Arrhythmia
Monitoring Devices Market Report Highlights
- The arrhythmia monitoring
devices market is highly competitive and is rapidly evolving with numerous
potential market players
- Holter monitors dominated
the market in terms of revenue in 2017. On the other hand, mobile cardiac
telemetry is expected to witness the fastest growth rate during the
forecast period
- Atrial fibrillation
dominated the market in terms of revenue in 2017. The growth in the number
of untreated cases of arrhythmias are leading to increasing need for
advanced cardiac monitoring devices
- Heightened adoption of
sophisticated technologies has led to the expansion of the market. Kardia
Mobile by AliveCor captures ECG in 30 seconds projecting the heart rhythm
for conditions such as atrial fibrillation
- The hospitals and clinics
segment held the largest share in the market in 2017. On the other hand,
diagnostic centers are likely to experience the fastest growth over the
forecast period
- North America commanded the
leading share in the market in 2017 due to faster regulatory approvals for
innovative devices and procedures
- AliveCor, Inc.; Applied
Cardiac Systems; BioTelemetry, Inc.; BIOTRONIK; Fukuda Denshi Co., Ltd.;
GE Healthcare; iRhythm; Medi-Lynx; St. Jude Medical (Abbott); Medtronic;
Nihon Kohden Corporation; Nuubo; and Spacelabs Healthcare are some of the
key players operating in this market.
Request a Sample Copy of the Report @
https://www.grandviewresearch.com/industry-analysis/arrhythmia-monitoring-devices-market/request/rs1
Arrhythmia Monitoring
Devices Market Segmentation
Grand View Research has segmented
the global arrhythmia monitoring devices market based on type, application, end
use, and region:
Arrhythmia
Monitoring Devices Type Outlook (Revenue, USD Million, 2014 - 2025)
- ECG Monitors
- Implantable Monitors
- Holter Monitors
- Mobile Cardiac Telemetry
Arrhythmia
Monitoring Devices Application Outlook (Revenue, USD Million, 2014 - 2025)
- Bradycardia
- Tachycardia
- Atrial Fibrillation
- Ventricular Fibrillation
- Premature Contraction
- Others
Arrhythmia
Monitoring Devices End Use Outlook (Revenue, USD Million, 2014 - 2025)
- Hospitals & Clinics
- Diagnostic Centers
- Others
Arrhythmia
Monitoring Devices Regional Outlook (Revenue, USD Million, 2014 - 2025)
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Italy
- Spain
- Asia Pacific
- Japan
- China
- India
- Latin America
- Brazil
- Mexico
- Middle East & Africa
- South Africa
About Grand View Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco. The
company provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, we offer
market intelligence studies ensuring relevant and fact-based research across a
range of industries, from technology to chemicals, materials and healthcare.
For more info visit @ https://www.grandviewresearch.com
No comments:
Post a Comment